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Accepted 10 March 2011AbstractObjective: This study was conducted to document the perinatal risk factors associated with early-onset neonatal Escherichia coli sepsis and
adverse neonatal outcomes.
Materials and Methods: A case-control study of early-onset E coli sepsis compared with that of non-E coli sepsis was conducted by a retro-
spective data review of all infants with a diagnosis of sepsis during the first 7 days of life from the pediatric unit of Mackay Memorial Hospital
from January 2004 to October 2008. After adjustment for gestational age, each patient with E coli early-onset sepsis was further compared with
two gestational age-matched uninfected controls.
Results: Compared with infants with non-E coli sepsis (n ¼ 27), infants with E coli sepsis (n ¼ 19) were more likely to have preterm birth,
especially at less than 30 weeks of gestation (47% vs. 4%, p < 0.01), very low birth weights (<1500 g; 47% vs. 4%, p < 0.01), intrapartum fever
(26% vs. 4%, p ¼ 0.036), preterm premature rupture of membranes (PPROM; 74% vs. 11%, p < 0.01), prolonged rupture of membranes (>24
hours; 47% vs. 0%, p < 0.01), antibiotic use (63% vs. 15%, p < 0.01), and sepsis onset on the first day of life (63% vs. 15%, p < 0.01). After
adjusting for gestational age, intrapartum fever (26% vs. 5%, p ¼ 0.035) and PPROM (74% vs. 39%, p ¼ 0.015) were more common in infants
with E coli sepsis. Fifteen of the 19 E coli isolates (79%) were ampicillin-resistant, and three (16%) were gentamicin-resistant. Antepartum and
intrapartum antibiotic exposure was associated with ampicillin-resistant E coli sepsis (100% vs. 43%, p < 0.01).
Conclusion: Early-onset E coli sepsis is more common in premature and very low birth weight infants and is more likely associated with
intrapartum fever, PPROM, and sepsis onset on the first day of life than non-E coli sepsis. Broad-spectrum, multiple antibiotics or longer
duration of antibiotic exposure may be associated with antibiotic-resistant pathogen infection.
Copyright  2012, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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Early-onset neonatal sepsis is an uncommon but important
cause of morbidity and mortality in infants, especially in those
with very low birth weight (VLBW) [1,2]. Group B strepto-
coccus (GBS) was the predominant cause of early-onset
neonatal sepsis in the past. After the development of guide-
lines for intrapartum antibiotic prophylaxis for GBS infection
[3,4], the incidence of early-onset neonatal sepsis caused by
GBS decreased, but there was an increased incidence of non-
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doi:10.1016/j.tjog.2012.01.006low-birth-weight, or VLBW neonates [5]. Escherichia coli is
a common pathogen in neonatal sepsis especially in preterm
infants. The overall incidence of E coli sepsis remained stable
after the introduction of intrapartum antibiotic prophylaxis,
but the incidence increased in VLBW infants [1,6]. In
premature infants, a growing problem of an increased trend in
the incidence of early-onset sepsis caused by antibiotic-
resistant E coli and other pathogens has been observed [6e8].
Several maternal factors and intrapartum events, including
intrapartum fever, the presence or prolonged rupture of
membranes, chorioamnionitis, maternal GBS colonization,
urinary tract infection, prematurity, and low birth weight, were
evaluated as neonatal sepsis risk factors in previous studies
[9e12]. Intrapartum antibiotic administration is effective in
preventing vertical GBS transmission and reducing maternalcs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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Gram-positive organisms (n ¼ 22)
b-Hemolytic streptococcus group B 2 12 14
Staphylococcus coagulase () 1 3 4
a-Streptococcus species 1 2 3
Enterococcus 1 1
Gram-negative organisms (n ¼ 24)
Escherichia coli 16 3 19
Klebsiella pneumonia 1 1
Acinetobacter baumannii 1 1
Serratia marcescens 1 1
Sphingomonas paucimobilis 1 1
Chryseobacterium meningosepticum 1 1
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of pathogens and their susceptibilities to antibiotics [5,13e17].
The objective of this study is to compare the maternal char-
acteristics, risk factors, and neonatal outcomes associated with
early-onset neonatal E coli sepsis with those of non-E coli
sepsis. We also analyzed infants with E coli sepsis with
gestational age-matched uninfected controls in an attempt to
assess the particular potential risk factors, patient characteris-
tics, and neonatal outcomes of early-onset E coli sepsis.
Materials and methods
This was a retrospective review of the data of all infants
with a diagnosis of sepsis during the first 7 days of life from
the pediatric unit at Mackay Memorial Hospital between
January 2004 and October 2008. Approval from the Institu-
tional Review Board of Mackay Memorial Hospital was
obtained. Early-onset sepsis was defined as symptoms and
signs of clinical sepsis in infants with pathogens isolated from
a blood or cerebrospinal fluid culture between birth and the
end of day 7 of life [18]. Onset of sepsis was defined as the
time of the first positive culture. We divided the infants into
two groupsdthose with E coli sepsis and those with non-E
coli sepsisdand compared their maternal characteristics, risk
factors, and neonatal outcomes. The patient characteristics and
clinical data of all sepsis cases were collected. Maternal
clinical data included age, parity, gestational age at delivery,
intrapartum fever, chorioamnionitis, duration of membrane
rupture, mode of delivery, and intrapartum antibiotic use. For
women who received intrapartum antibiotic therapy, data were
available on the total duration of therapy and the agents and
number of doses administered. Antibiotic use was defined as
receipt of at least one dose of antibiotics during the antepartum
or intrapartum period for treatment of infection or prophylaxis.
Neonatal clinical data included gestational age, birth weight,
onset of sepsis, antibiotic susceptibility of the pathogens,
Apgar score, ventilator use, intraventricular hemorrhage,
respiratory distress, neonatal intensive care unit admission,
length of hospital stay, and neonatal outcome.
A case-control study was also performed by comparing
each infant with early-onset E coli sepsis with two gestational
age-matched uninfected controls to identify the potential risk
factors of adverse neonatal outcomes other than gestational
age. The controls were matched with each case patient based
on gestational age (same gestational week) and closest
calendar month of birth (every control was born within 6
months of the birth of the respective case patient). Uninfected
controls with maternal systemic diseases, obstetric emergency
conditions, and maternal GBS colonization were excluded.
Univariable analysis was conducted to determine whether
there were significant differences in each variable between
the E coli sepsis group cases, non-E coli sepsis cases, and
controls. Statistical significance was determined using the chi-
square test or Fisher’s exact test for dichotomous variables
and by the independent t-test or ManneWhitney U-test for
continuous variables. A value of p < 0.05 was considered
statistically significant. The statistical analyses were performedwith SPSS version 12.0 software (SPSS Inc., Chicago,
IL, USA).
ResultsDistribution of pathogensForty-six cases of early-onset sepsis were identified by
clinical manifestations and positive neonatal blood cultures
during the study period. E coli sepsis was identified in 19
infants, while non-E coli sepsis was found in 27 infants. GBS
was the most common pathogen (50%, 12/24) in term infants,
but E coli was the predominant pathogen in preterm infants
(73%, 16/22). Twenty-two sepsis cases were caused by Gram-
positive organisms, and the other 24 cases were caused by
Gram-negative organisms, among which GBS (64%, 14/22)
and E coli (79%, 19/24) were the most common pathogens,
respectively (Table 1).Cases of E coli sepsis and non-E coli sepsisThe characteristics of patients with E coli sepsis and non-E
coli sepsis are shown in Table 2. Infants with E coli sepsis
cases had lower gestational ages and lower birth weights than
non-E coli sepsis infants, which was especially noted in those
with gestational ages less than 30 weeks and birth weights less
than 1500 gm (both 47% vs. 4%, p < 0.01). Intrapartum risk
factors for early-onset sepsis, such as intrapartum fever (26%
vs. 4%, p ¼ 0.036), preterm premature rupture of membranes
(PPROM; 74% vs. 11%, p < 0.01), and prolonged membrane
rupture (>24 hours; 47% vs. 0%, p < 0.01) were also more
common in the E coli sepsis group. Although there was no
significant difference in chorioamnionitis (21% vs. 4%,
p ¼ 0.085) between groups, it was also more common in the E
coli sepsis group. In addition, antibiotic use before delivery
was more common in the E coli sepsis group (63% vs.15%,
p < 0.01), and only two of the infants with non-E coli sepsis
received antibiotics as intrapartum prophylaxis for maternal
GBS colonization. Sixteen (84%) of the 19 early-onset E coli
sepsis infants were premature. Twelve (63%) of them had
Table 2
Analysis of maternal and neonatal variables in infants with early onset E coli






Maternal age (y) 33.1 (24e43)* 30 (24e36)* 0.027
Nulliparous 10 (53) 16 (59) 0.655
Gestational age (wk) 30.53 (24e39)* 37.67 (27e40)* < 0.01
＜30 9 (47) 1 (4)
30e36 7 (37) 5 (18)
S37 3 (16) 21 (78)





＜1500 9 (47) 1 (4)
1501e2500 4 (21) 5 (18)
S2500 6 (32) 21 (78)
Male gender 14 (74) 17 (63) 0.445
Vaginal delivery 10 (53) 15 (56) 0.845
Sepsis on d 1 12 (63) 4 (15) <0.01
Intrapartum fever 5 (26) 1 (4) 0.036
Chorioamnionitis 4 (21) 1 (4) 0.085
PPROM 14 (74) 3 (11) <0.01
&24 h 5 3
＞24 h 9 0
Intrapartum antibiotic
therapy
12 (63) 4 (15) <0.01
&7 d 4 4
＞7 d 8 0
1-min Apgar score < 7 10 (53) 2 (7) <0.01
5-min Apgar score < 7 5 (26) 2 (7) 0.091
Intraventricular hemorrhage 3 (16) 0 (0) 0.064
Respiratory distress 17 (89) 18 (67) 0.073
Mechanical ventilation use 14 (74) 6 (22) <0.01
Meningitis 4 (21) 5 (19) 0.559
NICU admission 16 (84) 16 (59) 0.07
Days in NICU (d) 18.63 (1e186)* 11.38 (1e62)* 0.057
Hospital stay of
survivors (d)
46.0 (16e241)* 22.33 (8e73)* 0.079
Death 6 (32) 3 (11) 0.09
Data are presented as n (%) or *mean (range).
NICU ¼ neonatal intensive-care unit; PPROM ¼ preterm premature rupture of
membranes.
Table 3
Analysis of maternal and neonatal variables in infants with early onset E coli






Birth weight (g) 1861 (614e4450)* 1713 (540e3666)* 0.609
Nulliparous 10 (53) 18 (47) 0.708
Male gender 14 (74) 24 (63) 0.427
Vaginal delivery 10 (53) 22 (58) 0.706
Intrapartum fever 5 (26) 2 (5) 0.035
Chorioamnionitis 4 (21) 3 (8) 0.159
PPROM 14 (74) 15 (39) 0.015
&24 h 5 5
＞24 h 9 10
Intrapartum antibiotic
therapy
12 (63) 17 (45) 0.19
&7 d 4 11
＞7 d 8 6
1-min Apgar score < 7 10 (53) 16 (42) 0.452
5-min Apgar score < 7 5 (26) 6 (16) 0.272
Intraventricular hemorrhage 3 (16) 3 (8) 0.313
Respiratory distress 17 (89) 34 (89) 0.661
Mechanical ventilation use 14 (74) 20 (53) 0.127
NICU admission 16 (84) 20 (53) 0.02
Days in NICU (d) 18.63 (1e186)* 51.4 (4e138) 0.033
Hospital stay of
survivors (d)
46.0 (16e241)* 43.81 (4e155)* 0.83
Death 6 (32) 6 (16) 0.151
Data are presented as n (%) or * mean (range).
NICU ¼ neonatal intensive-care unit; PPROM ¼ preterm premature rupture of
membranes.
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non-E coli sepsis group (63% vs. 15%, p < 0.01). The
proportions of 1-min Apgar score < 7 (53% vs. 7%, p < 0.01)
and mechanical ventilation use (74% vs. 22%, p < 0.01) were
higher in infants with E coli sepsis than those with non-E coli
sepsis. There were no differences in intraventricular hemor-
rhage, respiratory distress syndrome, and neonatal intensive-
care unit admission between groups. The overall mortality
rate was 20% (9/46). Although the E coli sepsis group had
a higher mortality rate than the non-E coli sepsis group, it did
not reach statistical significance (32% vs. 11%, p ¼ 0.09),
possibly because of the small number of cases, and other
conditions associated with the three deaths in the non-E coli
sepsis group, including tension pneumothorax and necrotizing
enterocolitis with bowel perforation. Nine neonates were born
before 30 weeks of gestation, and six of them died. Five of
these six infants died within 3 days.Cases of E coli sepsis and uninfected controlsAfter adjusting for gestational age, the proportion of
intrapartum fever and PPROM was more common in infants
with E coli sepsis than in uninfected controls (Table 3). Other
factors, including birth weight, chorioamnionitis, and antibi-
otic use before delivery, had no significant differences between
these two groups. There were also no differences between
these two groups in neonatal outcomes, including 1- or 5-min
Apgar score < 7, mechanical ventilation use, respiratory
distress, intraventricular hemorrhage, and mortality rate, but
a higher proportion of infants were admitted to the neonatal
intensive care unit in E coli sepsis compared with the unin-
fected controls (Table 3). All infants who died in the two
groups were delivered at less than 30 gestational weeks.Sensitivity of antibioticsAll isolates of E coli were further tested for antibiotic
susceptibility. Fifteen of the 19 E coli isolates (79%) were
ampicillin-resistant, and three (16%) were gentamicin-
resistant. There were no cases of third-generation cephalo-
sporin-resistant E coli in our study. Twelve mothers of infants
with early-onset E coli sepsis (63%, 12/19) received ampicillin
treatment before delivery, and three of them received multiple
antibiotics. Eight of them had antibiotic courses longer than 7
days. Infants with early-onset E coli sepsis who had antibiotics
Table 4
Analysis of variables in infants with early onset E coli sepsis with and without
antibiotic use before delivery.
With antibiotic
use (n ¼ 12)
Without antibiotic
use (n ¼ 7)
p
Antibiotic therapy ＞7 d 8
Multiple antibiotics 3
Prematurity 12 (100) 4 (57) 0.036
PPROM 12 (100) 2 (29) <0.01
Ampicillin-resistant E coli 12 (100) 3 (43) <0.01
Gentamicin-resistant E coli 3 (25) 0 (0) 0.227
Data are presented as n (%).
PPROM ¼ preterm premature rupture of membranes.
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vs. 57%, p ¼ 0.036) and PPROM (100% vs. 29%, p < 0.01)
than those without antibiotic use (Table 4).
Discussion
E coli and GBS were the most common isolates of gram-
negative and gram-positive pathogens in our study. Infants
with E coli sepsis were more likely to have preterm births
(84.2%), especially at less than 30 weeks of gestation,
VLBWs, intrapartum fever, PPROM, prolonged rupture of
membranes, antibiotic use, and sepsis onset on the first day.
Most of the E coli isolates (79%) were ampicillin-resistant,
which seemed to be associated with antepartum and intra-
partum antibiotic exposure.
An increase in mortality rate was observed in E coli sepsis,
although it did not reach statistical significance ( p ¼ 0.09)
because of the small case number in our series. E coli sepsis
is thought more likely to cause early fetal compromise in
premature infants. In our series, nine neonates were born at
less than 30 weeks of gestation, and six of them died. Thus, E
coli sepsis may increase the odds of mortality, especially in
infants born before 30 weeks of gestation. However, infants
who survive early-onset E coli sepsis may also have neuro-
developmental impairment [19].
In addition to gestational age, prematurity, and VLBW,
factors such as intrapartum fever, PPROM, and prolonged
membrane rupture were more common in the E coli sepsis
group than in the non-E coli group. A significant difference
was still observed in PPROM and intrapartum fever between
infants with E coli sepsis and gestational age-matched unin-
fected controls. These observations were similar to a report in
which PPROM was associated with adverse perinatal outcomes
and was an independent risk factor for chorioamnionitis [20].
Intrapartum fever and prolonged membrane rupture have been
associated with increased odds of E coli infection in both term
and preterm infants [9].
In recent years, there has been an increase in intrapartum
antibiotic prophylaxis to prevent the vertical transmission of
GBS. Antibiotic use may reduce maternal and neonatal illness
if PPROM or chorioamnionitis occurs [21e23], and it has
been effective against early-onset sepsis [9,16,24]. However,
antibiotic resistance is a potential problem associated withintrapartum antibiotic therapy [13,16,17] and long duration of
antibiotic use before delivery [25]. There are also trends of
increasing incidence of sepsis related to antibiotic-resistant E
coli and other pathogens [7,8,26]. In VLBW infants, the
incidence of antibiotic-resistant E coli sepsis has also
increased [1,6]. In our study, ampicillin-resistant strains were
found in 15 (79%) infants with E coli sepsis, who were all
VLBW infants, and there was an association between maternal
antibiotic use and ampicillin-resistant E coli sepsis. Because of
the increasing incidence of antibiotic-resistant E coli neonatal
sepsis, current empiric management of neonatal sepsis may
need reevaluation [27].
Ampicillin is commonly used for intrapartum prophylaxis
for GBS infection, and to reduce PPROM infection, cho-
rioamnionitis, urinary tract infection, and other infections
associated with maternal and neonatal illnesses in Taiwan. The
unnecessary, prolonged use of antibiotics may emerge as
a problem in sepsis related to neonatal antibiotic-resistant E
coli or other pathogens, and strategies in neonatal sepsis
management may need to be changed. In our study, most of
the florae causing E coli sepsis were resistant to ampicillin and
were seen in patients who received antepartum antibiotics
longer than 7 days. We further observed three infants with
gentamicin-resistant E coli sepsis. All of them received ante-
partum antibiotics. There is no clear evidence concerning the
use of gentamicin or other antibiotics to prevent neonatal
sepsis caused by ampicillin-resistant E coli or other pathogens.
Although the majority of pathogens causing neonatal sepsis
have been found susceptible to commonly used empiric first-
line antibiotic combinations which include gentamicin [28],
the efficacy of gentamicin for preventing neonatal sepsis is not
clear. When considering whether to add gentamicin or other
antibiotics to prevent neonatal ampicillin-resistant pathogen
infection, the possibility of selection of gentamicin-resistant or
even multiple antibiotic-resistant pathogens should be of
concern, especially in those given broad-spectrum or multiple
antibiotics and longer courses of antibiotics.
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